Table 1.
Demographic variables and baseline comorbidities.
|
| |||||
|---|---|---|---|---|---|
| GLOBAL (n = 1,435) | MEXICO (MX) (n = 262) | CENTRAL AMERICA AND CARIBBEAN (CAC) (n = 428) | SOUTH AMERICA (SAM) (n = 745) | p-VALUE* | |
|
| |||||
| Demographic Variables | |||||
|
| |||||
| Age (years) | 57.95 (SD 16.62) |
55.56 (SD 15.41) |
59.86 (SD 16.91) |
57.69 (SD 16.77) |
0.002 0.003 0.094 0.222 |
|
| |||||
| Male gender | 64.46% (925) | 58.40% (153) | 70.33% (301) | 63.22% (471) | 0.004 0.001 0.014 0.166 |
|
| |||||
| Baseline Comorbidities | |||||
|
| |||||
| Overweight/obesity (BMI ≥ 25) | 61.25% (879) | 80.92% (212) | 64.95% (278) | 52.21% (389) | 0.001 0.001 0.001 0.001 |
|
| |||||
| Overweight (BMI 25–29) |
35.75% (513) | 38.55% (101) | 43.93% (188) | 30.07% (224) | 0.001 0.165 0.001 0.012 |
|
| |||||
| Obesity(BMI ≥ 30) | 25.51% (366) | 42.37% (111) | 21.03% (90) | 22.15% (165) | 0.001 0.001 0.654 0.001 |
|
| |||||
| HBP | 45.37% (651) | 36.26% (95) | 60.28% (258) | 40.00% (298) | 0.001 0.001 0.001 0.286 |
|
| |||||
| DBT | 26.83% (385) | 34.35% (90) | 33.64% (144) | 20.27% (151) | 0.001 0.849 0.001 0.001 |
|
| |||||
| Former tobacco use | 14.15% (203) | 6.87% (18) | 19.63% (84) | 13.56% (101) | 0.001 0.001 0.006 0.004 |
|
| |||||
| Active tobacco use | 8.43% (121) | 13.74% (36) | 7.94% (34) | 6.85% (51) | 0.002 0.014 0.485 0.001 |
|
| |||||
| Ischemic heart disease | 6.76% (97) | 4.96% (13) | 9.58% (41) | 5.77% (43) | 0.019 0.028 0.015 0.623 |
|
| |||||
| COPD | 6.62% (95) | 2.67% (7) | 2.10% (9) | 10.60% (79) | 0.001 0.630 0.001 0.001 |
|
| |||||
| Renal failure | 4.32% (62) | 1.91% (5) | 2.80% (12) | 6.04% (45) | 0.003 0.462 0.013 0.008 |
|
| |||||
| Myocardiopathy | 4.74% (68) | 0.00% (0) | 9.11% (39) | 3.89% (29) | 0.001 0.001 0.001 0.001 |
|
| |||||
| Valvular heart disease | 1.74% (25) | 2.29% (6) | 2.57% (11) | 1.07% (8) | 0.128 N/A |
|
| |||||
| HIV | 0.42% (6) | 0.38% (1) | 0.00% (0) | 0.67% (5) | 0.229 N/A |
|
| |||||
Notes: * Each cell contains four p-values. The first p-value corresponds to chi-squared test (for categorical variables) or one-way ANOVA test (for numerical variables). Only a p ≤ 0.016 was considered statistically significance.
The second, third, and fourth p-values correspond to multiple comparisons between groups: Mx and CAC, CAC and SAm, and SAm and Mx, respectively. We used multiple chi-squared tests and ANOVA with Bonferroni correction.
HBP: high blood pressure; DBT: diabetes; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus.